Hunt Daniel W. 4
4 · Corvus Pharmaceuticals, Inc. · Filed Dec 15, 2017
Insider Transaction Report
Form 4
Hunt Daniel W.
SVP, Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-12-13+200,000→ 200,000 totalExercise: $10.60Exp: 2027-12-13→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on November 27, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.